This two-day conference will bring together representatives of the pharmaceutical and biotechnology industries and academic institutions to provide first-hand information on the latest oligonucleotide clinical candidates. It will also act as a platform for exchanging ideas on one of the biggest challenges facing the industry: how to deliver these new therapies.
